| 1 |
11942772 | Fenofibrate of gemfibrozil for treatment of types IIa and IIb primary hyperlipoproteinemia: a randomized, double-blind, crossover study. | 2002 Mar-Apr |
1 |
| 2 |
12025914 | Effect of ciprofibrate on C-reactive protein and fibrinogen levels. | 2002 May-Jun |
1 |
| 3 |
10789612 | Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group. | 2000 Apr 24 |
3 |
| 4 |
9678787 | Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia. | 1998 May |
4 |
| 5 |
9031453 | Modulation of plasma fibrinogen levels by ciprofibrate and gemfibrozil in primary hyperlipidaemia. | 1997 Jan |
1 |
| 6 |
9294990 | Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia. | 1997 Sep 1 |
1 |
| 7 |
9364979 | Effects of gemfibrozil and ciprofibrate on plasma levels of tissue-type plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen in hyperlipidaemic patients. | 1997 Oct |
3 |
| 8 |
8831919 | Ciprofibrate versus gemfibrozil in the treatment of primary hyperlipidaemia. | 1996 Jul |
1 |
| 9 |
7788039 | Long-term effect of gemfibrozil on coronary heart disease risk profile of patients with primary combined hyperlipidaemia. | 1995 Mar |
1 |
| 10 |
8236126 | Effect of three fibrate derivatives and of two HMG-CoA reductase inhibitors on plasma fibrinogen level in patients with primary hypercholesterolemia. | 1993 Aug 2 |
1 |
| 11 |
2076620 | Gemfibrozil in hyperlipidaemic patients with peripheral arterial disease: some undiscovered actions. | 1990 |
1 |